Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 18:17:2165-2174.
doi: 10.2147/IJWH.S522708. eCollection 2025.

Characteristics of Gut Microbiota in Patients with Polycystic Ovary Syndrome and Its Association with Metabolic Abnormalities: A Review

Shuang Liu  1 , Linqi Cheng  2 , Sen Li  3
Affiliations
Review

Characteristics of Gut Microbiota in Patients with Polycystic Ovary Syndrome and Its Association with Metabolic Abnormalities: A Review

Shuang Liu et al. Int J Womens Health. .

Abstract

Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder that has garnered attention in recent years for its intricate relationship with gut microbiota, which plays a significant role in the metabolic abnormalities associated with this condition. This review focuses on the characteristics of gut microbiota in polycystic ovary syndrome (PCOS). By analyzing current literature, we will focus on the alterations in gut microbiota composition, influential factors, and the pathophysiological mechanisms linking gut microbiota and PCOS, diagnostic approaches, therapeutic strategies, as well as controversies and future directions in this field are discussed. Understanding these relationships may provide insights into the disease mechanism and highlight novel treatment strategies for managing PCOS.

Keywords: endocrine disorders; gut microbiota; metabolic abnormalities; microbiome; polycystic ovary syndrome.

PubMed Disclaimer

Conflict of interest statement

All authors report no relevant conflicts of interest in this work.

References

    1. Yurtdaş G, Akdevelioğlu Y. A new approach to polycystic ovary syndrome: the gut microbiota. J Am Coll Nutr. 2020;39(4):371–382. doi: 10.1080/07315724.2019.1657515 - DOI - PubMed
    1. Yang Y, Cheng J, Liu C, et al. Gut microbiota in women with polycystic ovary syndrome: an individual based analysis of publicly available data. EClinicalMedicine. 2024;77:102884. doi: 10.1016/j.eclinm.2024.102884 - DOI - PMC - PubMed
    1. Sun Y, Gao S, Ye C, Zhao W. Gut microbiota dysbiosis in polycystic ovary syndrome: mechanisms of progression and clinical applications. Front Cell Infect Microbiol. 2023;13:1142041. doi: 10.3389/fcimb.2023.1142041 - DOI - PMC - PubMed
    1. Han Q, Wang J, Li W, Chen ZJ, Du Y. Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome. Microbiome. 2021;9(1):101. doi: 10.1186/s40168-021-01046-5 - DOI - PMC - PubMed
    1. Da Silva TR, Marchesan LB, Rampelotto PH, et al. Gut microbiota and gut-derived metabolites are altered and associated with dietary intake in women with polycystic ovary syndrome. J Ovarian Res. 2024;17(1):232. doi: 10.1186/s13048-024-01550-w - DOI - PMC - PubMed

LinkOut - more resources